Jared Kelly, Chief Executive Officer at ONCOLYTICS BIOTECH INC (ONCY), bought 5,050 shares at $0.96 ($5K) on 2026-03-12, disclosed to the SEC on 2026-03-13.
Open-market purchase of $5k ONCY by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.